stars 1 stars 2 stars 3

Immunethep is a biotech startup company that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. We are working on preventing and treating infectious diseases to improve global health (SDG#3) for a safer tomorrow free of AntiMicrobial Resistance (AMR). We will accomplish our mission by developing anti-infective immunotherapies that potentiate a natural and strong immune response from the infected host, reducing the disease burden and mortality rates.

IMMUNETHEP Questions

The IMMUNETHEP annual revenue was $6 million in 2026.

Pedro Madureira is the Co-founder and CSO of IMMUNETHEP.

13 people are employed at IMMUNETHEP.

IMMUNETHEP is based in Cantanhede, Coimbra.

The NAICS codes for IMMUNETHEP are [541, 54171, 5417, 54, 541713].

The SIC codes for IMMUNETHEP are [87, 873].

Top IMMUNETHEP Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users